By Monica Charsley A specialist research team have been granted up to £1.7m to fund a “groundbreaking” lung cancer vaccine for high risk patients. Scientists from the University of Oxford, the Francis Crick Institute and University College London (UCL) have created the life-changing jab, dubbed the “LungVax”, to kill cancer cells. The group used technology that was similar to the one that made the AstraZeneca Covid-19 vaccine. Cancer Research UK and the CRIS Cancer Foundation offered the funding to help the experts manufacture 3,000 doses of the jab. The injection works by using a strand of DN…
